Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy von Levstek, Tina, Vujkovac, Bojan, Cokan Vujkovac, Andreja, Trebušak Podkrajšek, Katarina

Volltext

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study von Linhart, AleÅ, Dostálová, Gabriela, Nicholls, Kathy, West, Michael L, Tandel, Camilla, Jovanovic, Ana, Giraldo, Pilar, Vujkovac, Bojan, Geberhiwot, Tarekegn, Brill-Almon, Einat, Alon, Sari, Chertkoff, Raul, Rocco, Rossana, Hughes, Derralynn

Volltext

Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease? von Hughes, Derralynn A, Aguiar, Patrício, Lidove, Olivier, Nicholls, Kathleen, Nowak, Albina, Thomas, Mark, Torra, Roser, Vujkovac, Bojan, West, Michael L, Feriozzi, Sandro

Volltext

Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease von Levstek, Tina, Breznik, Nika, Vujkovac, Bojan, Nowak, Albina, Trebušak Podkrajšek, Katarina

Volltext

Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease: Natural History Data from the Fabry Registry von Wanner, Christoph, Oliveira, João P, Ortiz, Alberto, Mauer, Michael, Germain, Dominique P, Linthorst, Gabor E, Serra, Andreas L, Maródi, László, Mignani, Renzo, Cianciaruso, Bruno, Vujkovac, Bojan, Lemay, Roberta, Beitner-Johnson, Dana, Waldek, Stephen, Warnock, David G

Volltext

Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified D... von Hughes, Derralynn A, Aguiar, Patricio, Deegan, Patrick B, Ezgu, Fatih, Frustaci, Andrea, Lidove, Olivier, Linhart, Aleš, Lubanda, Jean-Claude, Moon, James C, Nicholls, Kathleen, Niu, Dau-Ming, Nowak, Albina, Ramaswami, Uma, Reisin, Ricardo, Rozenfeld, Paula, Schiffmann, Raphael, Svarstad, Einar, Thomas, Mark, Torra, Roser, Vujkovac, Bojan, Warnock, David G, West, Michael L, Johnson, Jack, Rolfe, Mark J, Feriozzi, Sandro

Volltext

Fabry disease: diagnostic methods in nephrology practice von Vujkovac, Bojan

Volltext

Fabry disease: diagnostic methods in nephrology practice von Vujkovac, Bojan

Volltext

Cardiomyopathy and kidney function in agalsidase beta‐treated female Fabry patients: a pre‐treatment vs. post‐treatment analysis von Wanner, Christoph, Feldt‐Rasmussen, Ulla, Jovanovic, Ana, Linhart, Aleš, Yang, Meng, Ponce, Elvira, Brand, Eva, Germain, Dominique P., Hughes, Derralynn A., Jefferies, John L., Martins, Ana Maria, Nowak, Albina, Vujkovac, Bojan, Weidemann, Frank, West, Michael L., Ortiz, Alberto

Volltext

P005: Head-to-head trial of pegunigalsidase alfa vs agalsidase beta in Fabry disease: Phase 3 randomized, double-blind, BALANCE Study 2-year results von Bernat, John, Wallace, Eric, Goker-Alpan, Ozlem, Wilcox, William, Holida, Myrl, Longo, Nicola, Hughes, Derralynn, Giraldo, Pilar, Molnar, Maria, Ortiz, Damara, Hopkin, Robert, Tondel, Camilla, Linhart, Ales, Deegan, Patrick, Jovanovic, Ana, Muriello, Michael, Barshop, Bruce, Kimonis, Virginia, Vujkovac, Bojan, Nowak, Albina, Hiwot, Tarekegn, Pisani, Antonio, Germain, Dominique, Kantola, Ilkka, Knoll, Jasmine, Mehta, Ankit, Waldek, Stephen, Almon, Einat, Alon, Sari, Chertkoff, Raul, Rocco, Rossana, Warnock, David

Volltext

Urinary Total Globotriaosylceramide and Isoforms to Identify Women With Fabry Disease: A Diagnostic Test Study von Paschke, Eduard, PhD, Fauler, Guenter, PhD, Winkler, Heimo, BSc, Schlagenhauf, Axel, BSc, Plecko, Barbara, MD, Erwa, Wolfgang, MD, Breunig, Frank, MD, Urban, Wolfgang, MD, Vujkovac, Bojan, MD, Sunder-Plassmann, Gere, MD, Kotanko, Peter, MD

Volltext

Renal Replacement Therapy in Slovenia: Excerpts From 2013 Data von Buturović-Ponikvar, Jadranka, Gubenšek, Jakob, Arnol, Miha, Adamlje, Tone, Ceglar, Zlata, Damevska, Gabriela, Globokar, Mateja, Černe, Senka, Čufer, Andrej, Drozg, Andrej, Ekart, Robert, Knap, Bojan, Kandus, Aljoša, Kapun, Sonja, Kralj-Lopert, Simona, Klančič, Dimitrij, Kunc-Rešek, Natalija, Kralj, Stojan, Malovrh, Marko, Močivnik, Marjan, Novljan, Gregor, Romozi, Karmen, Rus, Igor, Saksida, Silvan, Vujkovac, Bojan, Ponikvar, Rafael

Volltext

An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease von Germain, Dominique P., Altarescu, Gheona, Barriales-Villa, Roberto, Mignani, Renzo, Pawlaczyk, Krzysztof, Pieruzzi, Federico, Terryn, Wim, Vujkovac, Bojan, Ortiz, Alberto

Volltext

Biomarkers of Fabry Nephropathy: Review and Future Perspective von Levstek, Tina, Vujkovac, Bojan, Trebusak Podkrajsek, Katarina

Volltext

Characteristics of Vascular Phenotype in Fabry Patients von Vujkovac, Andreja Cokan, Vujkovac, Bojan, Novaković, Srdjan, Števanec, Milan, Šabovič, Mišo

Volltext

Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial von Bakris, George L, Pitt, Bertram, Weir, Matthew R, Freeman, Mason W, Mayo, Martha R, Garza, Dahlia, Stasiv, Yuri, Zawadzki, Rezi, Berman, Lance, Bushinsky, David A

Volltext

Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference von Schiffmann, Raphael, Hughes, Derralynn A., Linthorst, Gabor E., Ortiz, Alberto, Svarstad, Einar, Warnock, David G., West, Michael L., Wanner, Christoph, Bichet, Daniel G., Christensen, Erik Ilsø, Correa-Rotter, Ricardo, Elliott, Perry M., Feriozzi, Sandro, Fogo, Agnes B., Germain, Dominique P., Hollak, Carla E.M., Hopkin, Robert J., Johnson, Jack, Kantola, Ilkka, Kopp, Jeffrey B., Kröner, Jürgen, Linhart, Aleš, Martins, Ana Maria, Matern, Dietrich, Mehta, Atul B., Mignani, Renzo, Najafian, Behzad, Narita, Ichiei, Nicholls, Kathy, Obrador, Greg T., Oliveira, João Paulo, Pisani, Antonio, Politei, Juan, Ramaswami, Uma, Ries, Markus, Terryn, Wim, Tøndel, Camilla, Torra, Roser, Vujkovac, Bojan, Waldek, Stephen, Walter, Jerry

Volltext

Tolerability of pegunigalsidase alfa across the clinical program: Integrated analysis of infusion-related reactions by dosing regimens von Hughes, Derralynn, Bernat, John, Linhart, Aleš, Longo, Nicola, Mehta, Ankit, Tøndel, Camilla, Vujkovac, Bojan, Rocco, Rossana, Koulinska, Irene, Chertkoff, Raul, Alon, Sari, Sakov, Anat, Wallace, Eric

Volltext

Tolerability of pegunigalsidase alfa across the clinical program: Integrated analysis of infusion-related reactions by prior enzyme replacement therapy von Mehta, Ankit, Wallace, Eric, Linhart, Aleš, Hughes, Derralynn, Longo, Nicola, Tøndel, Camilla, Vujkovac, Bojan, Rocco, Rossana, Koulinska, Irene, Chertkoff, Raul, Alon, Sari, Sakov, Anat, Bernat, John

Volltext

Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease von Cokan Vujkovac, Andreja, Novaković, Srdjan, Vujkovac, Bojan, Števanec, Milan, Škerl, Petra, Šabovič, Mišo

Volltext